NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

CHIMERIC THERAPEUTICS LIMITED (CHM)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of CHM: rating 2
(2 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Boardroom Pty Ltd
Level 8, 210 George Street, Sydney NSW 2000
Tel : +61 2 9290 9600 or 1300 737 760
Fax : +61 2 9279 0664 or 1300 653 459
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000121576
Address: Level 3, 62 Lygon Street Carlton South Vic 3053, Australia
Tel:  +61 3 98245254

Date first listed: 18/01/2021
Company Secretary: Nathan Jong, Phillip Hains
Activities: Chimeric is a biotechnology company developing a cancer cell therapy drug

News & Events

Expand this box to read and print

The suspension of trading in the options (ASX: CHMO) of Chimeric Therapeutics Limited will be lifted immediately.

28/03/2022

The options of Chimeric Therapeutics Limited will be suspended immediately, in accordance with Listing Rule 17.3, as deferred settlement trading will not be made available for them, as noted in CHM's Prospectus, announced to the market on 21 February 2022. The options are expected to be quoted on a normal settlement basis on Monday, 28 March 2022. The suspension only applies to the CHM's options and does not apply to any other quoted securities of CHM.

21/03/2022

listed entity carried for record purposes only

18/01/2021

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    04/07/2022George Matcham342,070$0.098$33,523
    29/06/2022Leslie Chong30,000$0.098$2,940
    03/12/2021Paul Hopper375,000$0.263$98,438
    04/08/2021George Matcham500,000$0.335$167,500
    08/03/2021Cindy Elkins24,800$0.318$7,881

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Paul HopperExecutive Chairman04/02/2020
    Jennifer ChowManaging Director, CEO30/08/2021
    Phillip HainsCFO06/10/2020
    Eric SullivanNon Exec Director30/08/2023
    Lesley RussellNon Exec Director18/01/2021

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Cindy ElkinsNon Exec Director01/02/202130/08/2023
    George MatchamNon Exec Director05/07/202103/08/2023
    Leslie ChongNon Exec Director18/01/202112/07/2023

    Date of first appointment, title may have changed.